Serum Hsa_circ_0005962 Is A Prognostic Biomarker of Paclitaxel Resistance in Nonsmall Cell Lung Cancer Treatment

BACKGROUND: Tumor progression and the therapeutic resistance associated with cancer agents are thought to be modulated by circular RNAs (circRNAs); however, its mechanism associated with nonsmall cell lung cancer (NSCLC) is still undetermined. The following investigation aimed to evaluate the involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chenliang, Xia, Shaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602696/
https://www.ncbi.nlm.nih.gov/pubmed/37901849
http://dx.doi.org/10.1155/2023/6644168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602696/
https://www.ncbi.nlm.nih.gov/pubmed/37901849
http://dx.doi.org/10.1155/2023/6644168

Ejemplares similares